Stockscreener 앱 받기
9.24
4.05%
-0.39
시장 영업 전:
9.33
0.09
+0.97%
Oric Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스
How to manage a losing position in ORIC Pharmaceuticals Inc.Free Triple Return Setup with Risk Control - Newser
Will a bounce in ORIC Pharmaceuticals Inc. offer an exitStock Entry Point Planner with Volume Spike - Newser
ORIC Pharmaceuticals Inc.’s volatility index tracking explainedFree Breakout Confirmation With Entry Tracker - Newser
Using flow based indicators on ORIC Pharmaceuticals Inc.Free Secure Return Focused Investment Plan - Newser
Volume spikes in ORIC Pharmaceuticals Inc. stock – what they meanAI Enhanced Strategy for Portfolio Growth - Newser
Will ORIC Pharmaceuticals Inc. continue its uptrendReal-Time Entry Forecast with Accuracy Metrics - Newser
What Fibonacci levels say about ORIC Pharmaceuticals Inc. reboundPrice Action Trading with Volume Confirmation - Newser
How to forecast ORIC Pharmaceuticals Inc. trends using time seriesPredictive System for Long-Term Stock Forecast - Newser
What data driven models say about ORIC Pharmaceuticals Inc.’s futureReal Stock Picks With Setup Verification - Newser
Is ORIC Pharmaceuticals Inc. a candidate for recovery playMonthly Long-Term Market Recap and Summary - Newser
Key resistance and support levels for ORIC Pharmaceuticals Inc.Bull Market Summary and Recovery Outlook - Newser
ORIC Pharmaceuticals Inc. stock momentum explainedEquity Signal Recap With Long-Term Summary - Newser
Is ORIC Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025In-Depth Stock Trading Volume Analysis - Newser
Using economic indicators to assess ORIC Pharmaceuticals Inc. potentialFree Risk Controlled Short Term Trade Plans - Newser
Vivo Capital LLC Purchases 802,632 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Using data filters to optimize entry into ORIC Pharmaceuticals Inc.Stock Market Watch with Smart Filters - Newser
Oric Pharmaceuticals (ORIC) to Release Quarterly Earnings on Monday - MarketBeat
Can ORIC Pharmaceuticals Inc. rally from current levelsFree Watchlist for Low Risk High Return - Newser
Oric Pharmaceuticals (ORIC) Projected to Post Quarterly Earnings on Monday - Defense World
ORIC Pharmaceuticals ORIC 2025Q2 Earnings Preview Upside Potential Due to Innovative Drug Development - AInvest
Market reaction to ORIC Pharmaceuticals Inc.’s recent newsWatchlist Generator for Smart Money Signals - Newser
Can swing trading help recover from ORIC Pharmaceuticals Inc. lossesFree Stock Screener With Smart Filters - Newser
How ORIC Pharmaceuticals Inc. stock performs during market volatilityShort-Term Growth Watch with Signal Prediction - Newser
What makes ORIC Pharmaceuticals Inc. stock price move sharplyDaily Market Momentum Summary and Strategy - Newser
Will ORIC Pharmaceuticals Inc. stock recover after recent dropFree Trade Setups With Clear Risk Limits - Newser
ORIC Pharmaceuticals: What It Takes To Be Best In Class (NASDAQ:ORIC) - Seeking Alpha
Is it too late to sell ORIC Pharmaceuticals Inc.AI-Powered Stock Trend Movement Analysis - Newser
ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding Update - MSN
Price momentum metrics for ORIC Pharmaceuticals Inc. explainedFree Low Risk Picks for Daily Trading - Newser
Chart Analysts Warn of Resistance Near ORIC Pharmaceuticals Inc. PriceLow Volatility Stable Growth Picks Rank High - metal.it
Victory Capital Management Inc. Boosts Stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Visualizing ORIC Pharmaceuticals Inc. stock with heatmapsEquity Signal Recap With Long-Term Summary - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):